Related Experiment Videos
[Utrogestan and high risk pregnancy]
Akusherstvo I Ginekologiia
|November 3, 2004
Summary
Utrogestan effectively treats threatened abortions in early pregnancy with minimal side effects. This natural progesterone treatment resulted in healthy pregnancies for most women in the study.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
Context:
- Threatened abortion in the first trimester is a common obstetric complication.
- Micronized natural progesterone, such as Utrogestan, offers a therapeutic option for managing early pregnancy complications.
Purpose:
- To evaluate the therapeutic efficacy and safety of Utrogestan in women experiencing threatened abortion during the first trimester.
- To assess the suitability of Utrogestan for oral administration in this patient group.
Summary:
- A retrospective study involved 68 women treated with 400 mg of Utrogestan daily for threatened abortion.
- Treatment duration averaged 21 days, administered orally.
- Sixty-one out of 68 women achieved healthy pregnancies with no significant side effects, apart from occasional mild headache or dizziness.
Impact:
- Utrogestan demonstrates significant effectiveness and a favorable safety profile for treating threatened abortions.
- The findings support the use of Utrogestan in obstetrics, particularly for threatened abortions and in women with pre-pregnancy luteal insufficiency.